Shri Banashankari Pharma Private Limited, a active private limited company, was established on 21 March 2014 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900KA2014PTC074302. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.10 M and a paid-up capital of ₹2.10 M.
It upholds a compliant status. Its leadership includes Phani Srinivas Ramella (Director), Paidiwar Srinivas (Director), Satya Murali Krishna Kammila (Director). Past directors included Venkata Krishna Kyathanahalli Nagaraj, Pavan Jain, Kyathanahalli Nagaraja Venkatesh. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at M. No: 562/105/1, Portion Ii, 1St Main Road, S R Compound, South City Road, Bannerugh, Atta Road,, Bangalore, Karnataka, 560076.
U74900KA2014PTC074302
074302
21 March 2014
₹2.10 M
₹2.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Shri Banashankari Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Phani Srinivas Ramella | Director | 24 Sep 2014 | Current |
| Paidiwar Srinivas | Director | 27 Aug 2019 | Current |
| Satya Murali Krishna Kammila | Director | 29 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Jul 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 24 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 19 Jan 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shri Banashankari Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.79% decrease. The company also saw a substantial improvement in profitability, with a 20.37% increase in profit. The company's net worth observed a substantial decline by a decrease of 47.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Shri Banashankari Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shri Banashankari Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shri Banashankari Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Banashankari Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shri Banashankari Pharma Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.
Shri Banashankari Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Progress on Satya Murali Krishna Kammila was appointed as a Director was appointed as a Director on 29 Sep 2021 & has been associated with this company since 4 years 3 months . was documented.
Progress on Paidiwar Srinivas was appointed as a Director was appointed as a Director on 27 Aug 2019 & has been associated with this company since 6 years 4 months . was documented.
Progress on Phani Srinivas Ramella was appointed as a Director was appointed as a Director on 24 Sep 2014 & has been associated with this company since 11 years 3 months . was documented.
The activity Shri Banashankari Pharma Private Limited was registered on 21 Mar 2014 with Roc Bangalore & aged 11 years 9 months as per MCA records. was completed.
The CIN of Shri Banashankari Pharma Private Limited is U74900KA2014PTC074302.
Shri Banashankari Pharma Private Limited is headquartered at M. No: 562/105/1, Portion Ii, 1St Main Road, S R Compound, South City Road, Bannerugh, Atta Road,, Bangalore, Karnataka, 560076.
Shri Banashankari Pharma Private Limited was incorporated on 21 March 2014.
The current directors of Shri Banashankari Pharma Private Limited are
The primary industry of Shri Banashankari Pharma Private Limited is Trade.
Shri Banashankari Pharma Private Limited is unlisted.
The authorized capital of Shri Banashankari Pharma Private Limited is ₹2.10 M, and the paid-up capital is ₹2.10 M.
The compliance status of Shri Banashankari Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX